Timing of infliximab and adalimumab initiation despite methotrexate in children with chronic non-infectious anterior uveitis

AIMS: Methotrexate (MTX) is standard treatment in pediatric chronic anterior uveitis (CAU). Addition of tumor necrosis factor-α inhibitors (TNFi) is often needed. We describe the timing and risk factors for TNFi use in children with CAU on MTX. METHODS: In this retrospective study, we reviewed 51 re...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eye (Lond)
Autors principals: McCracken, Courtney, Yeh, Steven, Jenkins, Kirsten, Travers, Curtis, Stryker, Daneka, Tommasello, Steven, Rouster-Stevens, Kelly A., Lambert, Scott R., Prahalad, Sampath, Drews-Botsch, Carolyn, Angeles-Han, Sheila T.
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6461976/
https://ncbi.nlm.nih.gov/pubmed/30487588
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41433-018-0283-0
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars